Sweden
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 714.00 M
|
Dec. 31, 2023 | USD 28.64 | 0.87% |
|
Sweden |
|
2 |
USD 585.19 M
|
Dec. 31, 2023 | USD 16.63 | 0.49% |
|
Sweden |
|
3 |
USD 297.84 M
|
April 30, 2024 | USD 5.39 | -0.39% |
|
Sweden |
|
4 |
USD 152.59 M
|
Dec. 31, 2023 | USD 12.08 | 1.50% |
|
Sweden |
|
5 |
USD 76.36 M
|
Dec. 31, 2023 | USD 3.41 | 3.24% |
|
Sweden |
|
6 |
USD 48.85 M
|
Dec. 31, 2023 | USD 9.75 | -0.95% |
|
Sweden |
|
7 |
USD 42.64 M
|
Dec. 31, 2023 | USD 11.98 | -2.51% |
|
Sweden |
|
8 |
USD 40.07 M
|
Dec. 31, 2023 | USD 20.58 | 0.68% |
|
Sweden |
|
9 |
USD 29.15 M
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
10 |
USD 20.46 M
|
Dec. 31, 2023 | USD 18.76 | 3.89% |
|
Sweden |
|
11 |
USD 12.49 M
|
Dec. 31, 2023 | USD 42.37 | 0.78% |
|
Sweden |
|
12 |
USD 11.41 M
|
Dec. 31, 2023 | USD 31.10 | 0.68% |
|
Sweden |
|
13 |
USD 6.51 M
|
Dec. 31, 2023 | USD 0.89 | 14.73% |
|
Sweden |
|
14 |
USD 6.37 M
|
Dec. 31, 2023 | USD 2.09 | -2.04% |
|
Sweden |
|
15 |
USD 4.83 M
|
Dec. 31, 2023 | USD 2.57 | -0.02% |
|
Sweden |
|
16 |
USD 3.10 M
|
Dec. 31, 2023 | USD 3.31 | 2.33% |
|
Sweden |
|
17 |
USD 3.00 M
|
Dec. 31, 2023 | USD 4.99 | 0.68% |
|
Sweden |
|
18 |
USD 2.86 M
|
Dec. 31, 2023 | USD 32.97 | -0.61% |
|
Sweden |
|
19 |
USD 1.14 M
|
Dec. 31, 2023 | USD 4.07 | -5.72% |
|
Sweden |
|
20 |
USD 792.92 K
|
April 30, 2024 | USD 1.60 | -0.43% |
|
Sweden |
|
21 |
USD 717.15 K
|
Dec. 31, 2023 | USD 0.45 | 23.08% |
|
Sweden |
|
22 |
USD 587.56 K
|
Dec. 31, 2023 | USD 0.25 | 0.32% |
|
Sweden |
|
23 |
USD 4.15 K
|
Dec. 31, 2023 | USD 0.29 | 0.68% |
|
Sweden |
|
24 |
USD 197.40
|
Dec. 31, 2023 | USD 0.13 | -6.51% |
|
Sweden |
|
25 |
USD -97.22 K
|
Dec. 31, 2023 | USD 0.43 | -0.78% |
|
Sweden |
|
26 |
USD -166.41 K
|
Dec. 31, 2023 | USD 0.84 | -0.17% |
|
Sweden |
|
27 |
USD -205.30 K
|
Dec. 31, 2023 | USD 0.14 | 1.34% |
|
Sweden |
|
28 |
USD -291.22 K
|
Dec. 31, 2023 | USD 0.09 | 1.68% |
|
Sweden |
|
29 |
USD -363.61 K
|
Dec. 31, 2023 | USD 1.88 | 0.68% |
|
Sweden |
|
30 |
USD -987.91 K
|
Dec. 31, 2023 | USD 0.11 | 1.51% |
|
Sweden |
|
31 |
USD -1.20 M
|
Aug. 31, 2024 | USD 0.30 | -1.39% |
|
Sweden |
|
32 |
USD -1.29 M
|
Dec. 31, 2023 | USD 1.01 | -1.50% |
|
Sweden |
|
33 |
USD -1.34 M
|
Dec. 31, 2023 | USD 0.61 | 0.68% |
|
Sweden |
|
34 |
USD -1.36 M
|
April 30, 2024 | USD 0.47 | -0.26% |
|
Sweden |
|
35 |
USD -1.49 M
|
Dec. 31, 2023 | USD 0.11 | 1.48% |
|
Sweden |
|
36 |
USD -1.65 M
|
Dec. 31, 2023 | USD 0.94 | 2.12% |
|
Sweden |
|
37 |
USD -1.69 M
|
Dec. 31, 2023 | USD 0.23 | 11.53% |
|
Sweden |
|
38 |
USD -1.93 M
|
Dec. 31, 2023 | USD 0.13 | -10.15% |
|
Sweden |
|
39 |
USD -2.04 M
|
Dec. 31, 2023 | USD 0.27 | 3.36% |
|
Sweden |
|
40 |
USD -2.07 M
|
Dec. 31, 2023 | USD 0.27 | -5.32% |
|
Sweden |
|
41 |
USD -2.66 M
|
Dec. 31, 2023 | USD 0.83 | 0.03% |
|
Sweden |
|
42 |
USD -3.20 M
|
Dec. 31, 2023 | USD 0.18 | 4.90% |
|
Sweden |
|
43 |
USD -3.49 M
|
Dec. 31, 2023 | USD 0.21 | 0.68% |
|
Sweden |
|
44 |
USD -3.65 M
|
Dec. 31, 2023 | USD 0.20 | 1.12% |
|
Sweden |
|
45 |
USD -3.66 M
|
Dec. 31, 2023 | USD 1.17 | -3.73% |
|
Sweden |
|
46 |
USD -3.74 M
|
Dec. 31, 2023 | USD 0.11 | 4.03% |
|
Sweden |
|
47 |
USD -3.75 M
|
Dec. 31, 2023 | USD 0.80 | 0.68% |
|
Sweden |
|
48 |
USD -3.97 M
|
Aug. 31, 2024 | USD 0.22 | -6.29% |
|
Sweden |
|
49 |
USD -4.06 M
|
Dec. 31, 2023 | USD 0.15 | -2.28% |
|
Sweden |
|
50 |
USD -4.32 M
|
Dec. 31, 2023 | USD 10.16 | -0.20% |
|
Sweden |
The Biotechnology company in Sweden with the highest EBITDA is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 714.00 M.
The Biotechnology company in Sweden with the lowest EBITDA is Vitrolife AB (publ) (Stockholm Stock Exchange: VITR.ST) at USD -314.36 M.
The top 10 Biotechnology companies in Sweden by EBITDA are Swedish Orphan Biovitrum AB (publ), Getinge AB (publ), Elekta AB (publ), AddLife AB (publ), Vimian Group AB (publ), BioGaia AB (publ), Biotage AB (publ), RaySearch Laboratories AB (publ), BioArctic AB (publ) and CellaVision AB (publ).
The bottom 10 Biotechnology companies in Sweden by EBITDA are Vitrolife AB (publ), Hansa Biopharma AB (publ), Egetis Therapeutics AB (publ), Vicore Pharma Holding AB (publ), BioInvent International AB (publ), Cantargia AB (publ), Oncopeptides AB (publ), SynAct Pharma AB, IRLAB Therapeutics AB (publ) and Xspray Pharma AB (publ).